Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE): A Pilot Randomized Controlled Trial

NCT04597437 is registered in ClinicalTrials.gov with George Washington University as lead sponsor.

NCT NCT04597437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04597437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE): A Pilot Randomized Controlled Trial
Lead sponsor
George Washington University
Phase
Phase 2
Overall status
Recruiting
Start date
March 15, 2024
Completion date
August 31, 2027
Enrollment
74 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dengue fever